Outcomes of topiramate for prophylaxis of chronic migraine headache.

Objectives: To explore the prophylactic outcome and tolerability of topiramate in patients suffering from chronic episodes of migraine.

Methods: A prospective, non-interventional study was conducted at the Neurology Department of Nishtar Medical University & Hospital Multan from 17th Aug 2020 to 17th Aug 2021. The eligible patients were administered topiramate (flexible dose) for six months while the treatment was continued for another six months upon the advice of the physician.